There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-15


IL-15 Molecule Information

Target Synonym:Interleukin-15;IL15;IL-15
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase ?

IL-15 Protein Product ListCompare or Buy

IL-15 Molecule Synonym Name


IL-15 Molecule Background

Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

IL-15 References

IL-15 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
OXS-C3550 OXS-3350; OXS-C3550 Preclinical University of Minnesota, GT Biopharma Acute myeloid Leukemia (AML) Details
Humanized mik-beta-1 mAb (National Cancer Institute) Hu-mik-beta-1 Phase Ⅰ National Cancer Institute Celiac disease Details
BJ-001 BJ-001 Phase Ⅰ BJ Bioscience Solid tumours, Infectious disease Details
SHR-1501 SHR-1501,SHR1501 Phase Ⅰ Jiangsu Hengrui Medicine Malignancies Details
Anti-interleukin-15-vaccine (CIGB) CIGB-50 Phase Ⅰ Center for Genetic Engineering and Biotechnology, Heber Biotech Rheumatoid arthritis (RA) Details
AMG-714 AMG-714; HuMab-IL15; PRV-015 Phase Ⅱ Genmab, Amgen, Celimmune, Provention Bio Celiac disease Details

This web search service is supported by Google Inc.